ICN Online Editor

rss feed

ICN Online Editor's Latest Posts

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

| August 14, 2018 | 0 Comments

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.   This week’s topic: Binge Eating Disorder   5 Journal Articles Binge eating, trauma, and suicide attempt in community […]

Continue Reading

Editorial Message and Issue Highlights–Vol. 15, No. 7–8, July-August 2018

Editorial Message and Issue Highlights–Vol. 15, No. 7–8, July-August 2018

| July 1, 2018 | 0 Comments

Continue Reading

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

| July 1, 2018 | 0 Comments

Continue Reading

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

| July 1, 2018 | 0 Comments

Continue Reading

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

| July 1, 2018 | 0 Comments

Continue Reading

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

| July 1, 2018 | 0 Comments

Continue Reading

Risk Management: Licensing Board Complaints: What You Need To Know

Risk Management: Licensing Board Complaints: What You Need To Know

| July 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

| July 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Regarding Zika Microcephaly

Letter to the Editor: Regarding Zika Microcephaly

| July 1, 2018 | 0 Comments

Continue Reading